Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma

BACKGROUND AND AIM: Limited-stage combined small cell esophageal carcinoma (LS-C-SCEC) is a rare, poorly understood, underdiagnosed disease, with components of both small cell esophageal cancer and non–small cell esophageal cancer. We investigated the optimal treatment strategy and prognostic factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huan-Huan, Zaorsky, Nicholas G, Meng, Mao-Bin, Wu, Zhi-Qiang, Zeng, Xian-Liang, Jiang, Bo, Jiang, Chao, Zhao, Lu-Jun, Yuan, Zhi-Yong, Wang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335610/
https://www.ncbi.nlm.nih.gov/pubmed/25709477
http://dx.doi.org/10.2147/OTT.S76048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335610/
https://www.ncbi.nlm.nih.gov/pubmed/25709477
http://dx.doi.org/10.2147/OTT.S76048

Ejemplares similares